Description
The National Institute of Arthritis and Musculoskeletal and Skin Diseases intends to publish a Notice of Funding Opportunity to solicit applications for continuing research on advancing the field of regenerative medicine using adult stem cells. The initiative will take advantage of remaining funds authorized through the 21st Century Cures Act.
• The opportunity is limited to investigator-initiated studies.
• Clinical trials are not allowed.
• The estimated funding for this opportunity is $400,000.
• Eligible applicants include public and state controlled institutions of higher education, nonprofits, small businesses, and others.
• The application response date is October 21, 2025.
• The estimated award date is June 22, 2026.
• The estimated project start date is July 21, 2026.